同型半胱氨酸及其与血栓闭塞性脉管炎发病机制研究进展
Advance in Research on Pathogenesis of Homocysteine Associated Thromboangiitis Obliterans
DOI: 10.12677/ACM.2016.64038, PDF, HTML, XML, 下载: 1,716  浏览: 2,347  国家自然科学基金支持
作者: 曾德创, 李天资：右江民族医学院附属医院，广西 百色
关键词: 同型半胱氨酸；血栓闭塞性脉管炎；发病机理；Homocysteine； Thromboangiitis Obliterans； Pathogenesis
摘要: 血栓闭塞性脉管炎(TAO)发生和发展的确切原因仍不清楚，目前比较明确的机制包括与MTHFR、CBS相关的基因缺陷导致同型半胱氨酸，B6、B12缺乏，吸烟、感染等遗传和环境因素在TAO中扮演了重要的角色，本病并不一定是由一种发病机制单独起作用，而有可能是多因素联合作用的结果，及其相互关系仍需更多的研究予以验证。
Abstract: The exact causes of the occurrence and development of thromboangiitis obliterans (TAO) are still unclear. So far, the mechanisms include the deficiency of homocysteine, vitamin B6 and B12 caused by the gene defect related to Methylene Tetrahydrofolate Reductase (MTHFR) and Cysta-thionine-β-synthase (CBS), smoking, infection, heredity and environment factors; and they play an important role in TAO. It’s probably that the TAO is the result of multi-factors rather than caused by only one single mechanism. The mutual relation between the factors still requires more research to prove.
文章引用：曾德创, 李天资. 同型半胱氨酸及其与血栓闭塞性脉管炎发病机制研究进展[J]. 临床医学进展, 2016, 6(4): 202-206. http://dx.doi.org/10.12677/ACM.2016.64038

参考文献

[1] Shankle, W.R., Hara, J., Barrentine, L.W., et al. (2016) Cerefolin NAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease. Journal of Alzheimer’s Disease, 54, 1073-1084. https://doi.org/10.3233/JAD-160241
[2] Hrncic, D., Mikić, J., Rasic-Markovic, A., et al. (2016) Anxiety-Related Behavior in hyperhomocysteinemia Induced by Methionine Nutritional Overload in Rats: Role of the Brain Oxidative Stress. Canadian Journal of Physiology and Pharmacology, 94, 1074-1082. https://doi.org/10.1139/cjpp-2015-0581
[3] Hemanth Kumar, B., Dinesh Kumar, B. and Diwan, P.V. (2016) Hes-peridin, a Citrus Flavonoid, Protects against l-Methionine-Induced Hyperhomocysteinemia by Abrogation of Oxidative Stress, Endothelial Dysfunction and Neurotoxicity in Wistar Rats. Pharmaceutical Biology, 27, 1-10. https://doi.org/10.1080/13880209.2016.1231695
[4] Paul, R. and Borah, A. (2016) L-DOPA-Induced Hyperhomo-cysteinemia in Parkinson’s Disease: Elephant in the Room. Biochimica et Biophysica Acta, 1860, 1989-1997. https://doi.org/10.1016/j.bbagen.2016.06.018
[5] Gao, L., Kolanuvada, B., Naik, G., et al. (2016) Hyperhomocyste-inemia-Induced Upper Extremity Deep Vein Thrombosis and Pulmonary Embolism in a Patient with Methyltetrahy-drofolate Reductase Mutation: A Case Report and Literature Review. Blood Coagulation & Fibrinolysis, 27, 720-723. https://doi.org/10.1097/MBC.0000000000000458
[6] Toda, N. and Okamura, T. (2016) Hyperhomocysteinemia Im-pairs Regional Blood Flow: Involvements of Endothelial and Neuronal Nitric Oxide. Pflügers Archiv, 468, 1517-1525. https://doi.org/10.1007/s00424-016-1849-y
[7] Naseri, M., Sarvari, G.R., Esmaeeli, M., et al. (2016) High Doses of Oral Folate and Sublingual Vitamin B12 in Dialysis Patients with Hyperhomocysteinemia. Journal of Renal Injury Prevention, 5, 134-139. https://doi.org/10.15171/jrip.2016.28
[8] Deminice, R., Cella, P.S., Padilha, C.S., et al. (2016) Creatine Supple-mentation Prevents Hyperhomocysteinemia, Oxidative Stress and Cancer-Induced Cachexia Progression in Walker-256 Tumor-Bearing Rats. Amino Acids, 48, 2015-2024. https://doi.org/10.1007/s00726-016-2172-9
[9] Ibrahimagic, O.C., Smajlovic, D., Dostovic, Z., et al. (2016) Hyperhomocysteinemia and Its Treatment in Patients with Parkinson’s Disease. Materia Socio Medica, 28, 303-306. https://doi.org/10.5455/msm.2016.28.303-306
[10] Chung, Y.C., Kruyer, A., Yao, Y., et al. (2016) Hyperhomocysteinemia Exacerbates Alzheimer’s Disease Pathology by Way of the β-Amyloid Fibrinogen Interaction. Journal of Thrombosis and Haemostasis, 14, 1442-1452. https://doi.org/10.1111/jth.13340
[11] Korai, M., Kitazato, K.T., Tada Y., et al. (2016) Hyperhomocysteinemia Induced by Excessive Methionine Intake Promotes Rupture of Cerebral Aneurysms in Ovariectomized Rats. Journal of Neuroinflammation, 13, 165. https://doi.org/10.1186/s12974-016-0634-3
[12] Molina-López, J., Florea, D., Quintero-Osso, B., de la Cruzemail, A.P., Rodríguez-Elviraemail, M. and del Pozo, E.P. (2016) Pyridoxal-5’-Phosphate Deficiency Is Associated with Hyperhomocysteinemia Regardless of Antioxidant, Thiamine, Riboflavin, Cobalamine, and Folate Status in Critically Ill Patients. Clinical Nutrition, 35, 706-712. https://doi.org/10.1016/j.clnu.2015.04.022
[13] Hainsworth, A.H., Yeo, N.E., Weekman, E.M. and Wilcock, D.M. (2016) Homocysteine, Hyperhomocysteinemia and Vascular Contributions to Cognitive Impairment and Dementia (VCID). Biochimica et Biophysica Acta, 1862, 1008- 1017. https://doi.org/10.1016/j.bbadis.2015.11.015
[14] Bhanji, R.A., Ma, M., Bain, V.G. and Montano-Loza, A.J. (2016) Hyperhomocysteinemia Is Associated with Severity of Cir-rhosis and Negative Impact after Liver Transplantation. Liver International, 36, 696-704. https://doi.org/10.1111/liv.12979
[15] Veeranki, S., Gandhapudi, S.K. and Tyagi, S.C. (2016) Interactions of Hyper-homocysteinemia and T Cell Immunity in Causation of Hypertension. Canadian Journal of Physiology and Pharma-cology, 28, 1-8. https://doi.org/10.1139/cjpp-2015-0568
[16] Bhargava, S., Bhargava, M.S., Bhargava, E.K. and Srivastava, L.M. (2016) Hyperhomocysteinemia, MMPs and Cochlear Function: A Short Review. Indian Journal of Clinical Biochemistry, 31, 148-151. https://doi.org/10.1007/s12291-015-0505-1
[17] Bonetti, F., Brombo, G. and Zuliani, G. (2016) The Relationship be-tween Hyperhomocysteinemia and Neurodegeneration. Neurodegenerative Disease Management, 6, 133-145. https://doi.org/10.2217/nmt-2015-0008
[18] Kocak, B. and Ustun, E.D. (2016) Vasa Nervorum as the Source of Corkscrew Collaterals in Thromboangiitis Obliterans (Buerger’s Disease). European Journal of Vascular and Endo-vascular Surgery, 52, 508. https://doi.org/10.1016/j.ejvs.2016.07.017
[19] 刘焱喆, 王勤运, 王海涛, 等. 血栓闭塞性脉管炎治疗进展[J]. 现代生物医学进展, 2014, 14(27): 5397-5400.
[20] Rivera-Chavarría, I.J. and Brenes-Gutiérrez, J.D. (2016) Thrombo-angiitis Obliterans (Buerger’s Disease). Annals of Medicine and Surgery, 7, 79-82. https://doi.org/10.1016/j.amsu.2016.03.028
[21] Aszalos, C., Dongó, E., Farkas, Z., et al. (2016) Cerebral Manifesta-tions of Thromboangiitis Obliterans. Case Report. Orvosi Hetilap, 157, 1207-1211. https://doi.org/10.1556/650.2016.30476
[22] Rimar, D., Rozenbaum, M., Slobodin, G., Boulman, N., KaLy, L. and Rosner, I. (2016) Thromboangiitis Obliterans Overlapping with Atherosclerotic Occlusive Arterial Disease: Small Mesenteric Artery Involvement by Thromboangiitis Obliterans. Harefuah, 155, 41-44.
[23] Abyshov, N.S., Abdullaev, A.G., Zakirdzhaev, E.D., et al. (2016) The Results of Combined Surgical Treatment of Thromboangiitis Obliterans and Critical Lower Limb Ischemia Using Prolonged Epidural Analgesia and Autohemotherapy with Ozone. Khirurgiia, 45-50.
[24] 赵文光, 王征. 血栓闭塞性脉管炎的研究现状[J]. 中华普通外科杂志, 2002, 17(5): 319-320.
[25] Soni, C.V., Tyagi, S.C., Todnem, N.D., et al. (2016) Hyperhomocysteinemia Alters Sinoatrial and Atrioventricular Nodal Function: Role of Magnesium in Attenuating These Effects. Cell Biochemistry and Biophysics, 74, 59-65. https://doi.org/10.1007/s12013-015-0711-8
[26] Kolling, J., Scherer, E.B., Siebert, C., et al. (2016) Severe Hyperho-mocysteinemia Decreases Respiratory Enzyme and Na+-K+ ATPase Activities, and Leads to Mitochondrial Alterations in Rat Amygdala. Neurotoxicity Research, 29, 408-418. https://doi.org/10.1007/s12640-015-9587-z
[27] Van Dijk, S.C., Enneman, A.W., Swart, K.M., et al. (2016) Effect of Vitamin B12 and Folic Acid Supplementation on Biomarkers of Endothelial Function and Inflammation among Elderly Individuals with Hyperhomocysteinemia. Vascular Medicine, 21, 91-98. https://doi.org/10.1177/1358863X15622281
[28] Ventura, P., Venturelli, G., Marcacci, M., et al. (2016) Hyperhomocysteinemia and MTHFR C677T Polymorphism in Patients with Portal Vein Thrombosis Complicating Liver Cirrhosis. Thrombosis Research, 141, 189-195. https://doi.org/10.1016/j.thromres.2016.03.024

为你推荐